Vimovo and Ultram drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vimovo (esomeprazole magnesium; naproxen) and Ultram (tramadol hydrochloride). Common drug interactions include arrhythmia among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Vimovo and Ultram. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Vimovo?

Vimovo has active ingredients of esomeprazole magnesium; naproxen. It is often used in osteoarthritis. eHealthMe is studying from 9,608 Vimovo users. Check the latest studies of Vimovo.

What is Ultram?

Ultram has active ingredients of tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 28,425 Ultram users. Check the latest studies of Ultram.



On Jul, 11, 2026

23 people who take Vimovo and Ultram together, and have interactions are studied.

Vimovo and Ultram drug interactions.

What are the common drug interactions of Vimovo and Ultram, by gender? *:

female:

  1. Arrhythmia (irregular heartbeat)
  2. Carotid artery stenosis (narrowing of carotid artery)
  3. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  4. Cough
  5. Drug hypersensitivity
  6. Dyspepsia (indigestion)
  7. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  8. Headache (pain in head)
  9. Heart rate increased
  10. Hypertension (high blood pressure)

male:

  1. Renal failure (kidney dysfunction)
  2. Oesophagitis (inflammation of oesophagus)

What are the common drug interactions of Vimovo and Ultram, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Drug effect increased
  2. Hypokalaemia (low potassium)
  3. Nausea (feeling of having an urge to vomit)
  4. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  5. Renal failure (kidney dysfunction)
  6. Somnolence (a state of near-sleep, a strong desire for sleep)

50-59:

  1. Headache (pain in head)
  2. Heart rate increased
  3. Hypertension (high blood pressure)
  4. Lymphadenopathy (disease or enlargement of lymph nodes)
  5. Mitral valve incompetence (inefficient heart valve)
  6. Nasopharyngitis (inflammation of the nasopharynx)
  7. Nausea (feeling of having an urge to vomit)
  8. Non-cardiac chest pain
  9. Oropharyngeal pain
  10. Palpitations (feelings or sensations that your heart is pounding or racing)

60+:

  1. Chronic kidney disease
  2. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 26.09%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 21.74%
  3. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 13.04%
  4. High Blood Pressure: 3 people, 13.04%
  5. Psoriasis (immune-mediated disease that affects the skin): 2 people, 8.70%
  6. Indigestion: 2 people, 8.70%
  7. Hypersensitivity: 2 people, 8.70%
  8. High Blood Cholesterol: 2 people, 8.70%
  9. Erosive Oesophagitis (acid reflux disease can cause tissue damage in the oesophagus over time): 2 people, 8.70%
  10. Asthma: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Vimovo and Ultram?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Vimovo and Ultram:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Vimovo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ultram:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vimovo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ultram and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on esomeprazole magnesium; naproxen and tramadol hydrochloride (the active ingredients of Vimovo and Ultram, respectively), and Vimovo and Ultram (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: